This interdisciplinary coordinated research action aims at elucidating geneenvironment interactions in three highly prevalent smoking-induced lung diseases with important morbidity, disability and mortality: asthma, chronic obstructive pulmonary disease COPD) and lung cancer. Ultimately, the aim is to elucidate pathogenetic pathways and networks, to identify new targets and to develop new drugs to alleviate these common respiratory diseases.